Dow Up 0.64% Nasdaq Up 0.68%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
1.15 0.07(6.48%) Sep 18, 3:59PM EDT
Prev Close:1.08
Open:1.11
Bid:1.05 x 4000
Ask:1.25 x 1500
1y Target Est:5.00
Beta:1.41
Next Earnings Date:N/A
Day's Range:1.09 - 1.19
52wk Range:1.08 - 2.56
Volume:625,964
Avg Vol (3m):170,364
Market Cap:31.92M
P/E (ttm):N/A
EPS (ttm):-0.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OPXA

Comparison

Symbol% ChgMkt Cap
OPXAUp 6.48%31.92M
SNY149.53B
TEVA44.74B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.56
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback